Edenlux’s Eye-Strain Wellness Device Launches in the U.S.
▼ Summary
– High daily smartphone use is linked to various eye health issues, including eye fatigue, dry eyes, and the worsening of nearsightedness.
– Edenlux, a startup founded by Dr. Sungyong Park, develops wellness devices to address eye and ear problems caused by digital device overuse, inspired by Park’s personal experience with vision loss.
– The company’s upcoming device, Eyeary, is a daily visual recovery tool for the U.S. market designed to be faster and more comfortable than its first product, Otus, which generated $10 million in revenue.
– Edenlux’s technology, such as Eyeary’s 144 diopter focal points, trains the eye’s ciliary muscle and uses an app with AI to customize programs and predict improvement timelines based on collected data.
– The company has raised significant funding, established a U.S. subsidiary, and is exploring partnerships with major tech firms to integrate its vision-protecting technology into mainstream devices.
Modern lifestyles demand constant engagement with digital screens, a reality that has fundamentally altered how we use our eyes. Research consistently shows that the average adult now spends over six hours daily in front of screens, a habit strongly linked to a host of visual discomforts. These issues range from dry eyes and persistent fatigue to blurred vision, headaches, and the acceleration of nearsightedness. In response to this growing public health concern, the South Korean wellness technology startup Edenlux is introducing its latest device, Eyeary, to the U.S. market.
The company’s origin story is deeply personal. Founder and CEO Sungyong Park, a medical doctor, experienced a sudden and alarming loss of his own focusing ability due to a rare reaction to a muscle relaxant. Told by specialists to simply wait for a potential recovery, Park took matters into his own hands. He sourced specialized ophthalmic equipment and began a rigorous process of retraining his eye muscles, which ultimately restored his vision. This transformative journey inspired him to pivot from medicine to entrepreneurship, founding Edenlux with a mission to develop accessible technology for vision preservation and recovery.
Edenlux is now gearing up to launch Eyeary, its second product, via an Indiegogo campaign slated for late March. Positioned as a daily visual recovery tool, it falls under the U.S. FDA’s wellness category, allowing it to be marketed for vision training and general eye health support. The company chose this crowdfunding route over seeking additional investor capital, citing strong existing cash reserves.
This new device represents a significant evolution from Edenlux’s first product, Otus. Launched in 2022 across several Asian markets, the VR-style Otus device has reportedly generated $10 million in cumulative revenue by using lenses to exercise the eye’s ciliary muscle. While effective, Park notes that users of Otus typically saw results, like reduced dependence on reading glasses, over approximately 12 months. He claims that Eyeary is designed to achieve similar outcomes in about half that time, around six months.
A major advancement with Eyeary is its user-friendly design. Engineered to resemble a pair of ordinary glasses, it is lighter and more comfortable than its predecessor. Its technical core is also more sophisticated, featuring a lens system with 144 diopter focal points for finer adjustments and more precise muscle training, a substantial upgrade from Otus’s five focal points. The device connects via Bluetooth to a companion mobile app, which collects usage data and transmits it to Edenlux’s servers. The company then employs AI to analyze this anonymized data, factoring in age, gender, and vision profiles, to predict improvement timelines and personalize training regimens for users.
The science behind the technology addresses a specific physiological problem. Extended periods of staring at nearby screens cause the ciliary muscle, which controls the eye’s lens, to remain in a constant state of contraction. Over time, this can lead to weakening and fatigue, manifesting as the common symptoms of digital eye strain. Edenlux’s approach is to actively exercise and relax this muscle to restore its flexibility and strength.
Looking beyond Eyeary, Edenlux has developed a broader product ecosystem targeting specific conditions. This suite includes Tearmore for dry eye, Lux-S for strabismus, Lumia for myopia prevention, and Heary for auditory recovery, with these additional devices planned for initial rollout in Asian markets.
Park views companies like Oura Ring as conceptual peers in the wellness tech space, as both collect biometric data and deliver insights through software, often on a subscription basis. However, Edenlux carves its own niche by focusing exclusively on vision and hearing health issues stemming from digital device overuse. The company’s target audience is broad: essentially anyone who regularly uses a smartphone or earphones.
To support its global ambitions, Edenlux has established a U.S. subsidiary in Dallas, Texas, where final device assembly will occur. The startup is well-capitalized, having raised $39 million in a 2020 Series A round and a further $60 million in a 2022 Series B. While it currently handles all development and manufacturing internally, Edenlux is exploring potential partnerships with major technology firms like Apple or Samsung, with the goal of integrating its vision-protection technology directly into smartphones and other ubiquitous devices.
By merging medical insight with hardware innovation and data science, Edenlux is positioning eye wellness not merely as a passing trend but as a critical and enduring frontier in consumer technology.
(Source: TechCrunch)
